Literature DB >> 7995362

Low prevalence of antibody to human parvovirus B19 in Singapore.

Y Matsunaga1, K T Goh, E Utagawa, N Muroi.   

Abstract

A seroepidemiological survey was conducted in Singapore to assess the prevalence of antibody to human parvovirus B19. Sera were collected from 600 healthy individuals between 6 months and over 50 years of age and tested for IgG antibody against B19 virus by antigen capture indirect immunosorbent assay. The overall seropositivity rate was 16.2%. All the children under 5 years of age were seronegative. Antibody prevalence increased gradually from 3.5% in school children (5-14 years of age) to 7.7% in age group 15-19 years and then to 10.3% in young adults (20-24 years of age). In the age group 25-34 years the prevalence was 28% and in the age group over 35 years 65% had parvovirus B19 antibody. The results of the survey indicate that there has been very low incidence of B19 virus infection in Singapore during the last two decades.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7995362      PMCID: PMC2271324          DOI: 10.1017/s0950268800068552

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  10 in total

1.  Prevalence of varicella-zoster virus infection in Singapore.

Authors:  P L Ooi; K T Goh; S Doraisingham; A E Ling
Journal:  Southeast Asian J Trop Med Public Health       Date:  1992-03       Impact factor: 0.267

2.  [Incidence of parvovirus B19 infection. Seroepidemiologic studies].

Authors:  T F Schwarz; M Roggendorf; F Deinhardt
Journal:  Dtsch Med Wochenschr       Date:  1987-10-02       Impact factor: 0.628

3.  Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands.

Authors:  T F Schwarz; L G Gürtler; G Zoulek; F Deinhardt; M Roggendorf
Journal:  Zentralbl Bakteriol       Date:  1989-07

4.  The prevalence of antibody to human parvovirus B19 in England and Wales.

Authors:  B J Cohen; M M Buckley
Journal:  J Med Microbiol       Date:  1988-02       Impact factor: 2.472

5.  The prevalence of antibody to hepatitis A virus in Singapore.

Authors:  K T Goh; L Y Wong; C J Oon; S Kumarapathy
Journal:  Asia Pac J Public Health       Date:  1987       Impact factor: 1.399

6.  An outbreak of hand, foot, and mouth disease in Singapore.

Authors:  K T Goh; S Doraisingham; J L Tan; G N Lim; S E Chew
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

7.  Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.

Authors:  L J Anderson; C Tsou; R A Parker; T L Chorba; H Wulff; P Tattersall; P P Mortimer
Journal:  J Clin Microbiol       Date:  1986-10       Impact factor: 5.948

8.  Human parvovirus (B19) and erythema infectiosum.

Authors:  T Nunoue; K Okochi; P P Mortimer; B J Cohen
Journal:  J Pediatr       Date:  1985-07       Impact factor: 4.406

9.  A significant age shift of the human parvovirus B19 antibody prevalence among young adults in Japan observed in a decade.

Authors:  K Yamashita; Y Matsunaga; J Taylor-Wiedeman; S Yamazaki
Journal:  Jpn J Med Sci Biol       Date:  1992-04

10.  Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil.

Authors:  R B de Freitas; D Wong; F Boswell; M F de Miranda; A C Linhares; J Shirley; U Desselberger
Journal:  J Med Virol       Date:  1990-12       Impact factor: 2.327

  10 in total
  6 in total

1.  Seroepidemiology of parvovirus B19 among different age groups & pregnant women in India.

Authors:  Rajlakshmi Viswanathan; Babasaheb V Tandale; Manisha S Tamayachekar; Santoshkumar M Jadhav; Kirtee A Khutwad; Kiran R Munne
Journal:  Indian J Med Res       Date:  2017-07       Impact factor: 2.375

2.  Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors.

Authors:  Janak Kishore; Manisha Srivastava; Nabjyoti Choudhary
Journal:  Asian J Transfus Sci       Date:  2010-07

3.  Parvovirus B19V infection in Israel: prevalence and occurrence of acute infection between 2008 and 2013.

Authors:  O Mor; I Ofir; R Pavel; R Bassal; Z Kra-Oz; D Cohen; T Shohat; E Mendelson
Journal:  Epidemiol Infect       Date:  2015-05-20       Impact factor: 4.434

4.  Seroepidemiology of parvovirus B19 in the Frankfurt am Main area, Germany: evaluation of risk factors.

Authors:  C Reinheimer; R Allwinn; H W Doerr; M Wittek
Journal:  Infection       Date:  2010-06-17       Impact factor: 7.455

5.  Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia.

Authors:  Helen M Faddy; Elise C Gorman; Veronica C Hoad; Francesca D Frentiu; Sarah Tozer; R L P Flower
Journal:  BMC Infect Dis       Date:  2018-12-07       Impact factor: 3.090

Review 6.  Seroprevalence of ToRCH Pathogens in Southeast Asia.

Authors:  Franziska E Fuchs; Maude Pauly; Antony P Black; Judith M Hübschen
Journal:  Microorganisms       Date:  2021-03-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.